ATOS Atossa Therapeutics

Atossa Therapeutics Inc.
Companies
1993+
Filing Dates

362 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
S-1
ATOS Atossa Therapeutics Inc.
20 Nov 20
IPO registration
10-Q
2020 Q3
ATOS Atossa Therapeutics Inc.
13 Nov 20
Quarterly report
8-K
ATOS Atossa Therapeutics Inc.
13 Nov 20
Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
8-K
ATOS Atossa Therapeutics Inc.
25 Sep 20
Entry into a Material Definitive Agreement
424B3
ATOS Atossa Therapeutics Inc.
25 Sep 20
Prospectus supplement
EFFECT
ATOS Atossa Therapeutics Inc.
11 Sep 20
Notice of effectiveness
CORRESP
ATOS Atossa Therapeutics Inc.
8 Sep 20
Correspondence with SEC
UPLOAD
ATOS Atossa Therapeutics Inc.
8 Sep 20
Letter from SEC
S-3
ATOS Atossa Therapeutics Inc.
2 Sep 20
Shelf registration
10-Q
2020 Q2
ATOS Atossa Therapeutics Inc.
13 Aug 20
Quarterly report
8-K
ATOS Atossa Therapeutics Inc.
13 Aug 20
Atossa Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
4
Remmel H. Lawrence
19 May 20
ATOSSA THERAPEUTICS / H. Lawrence Remmel ownership change
4
ATOS Atossa Therapeutics Inc.
19 May 20
ATOSSA THERAPEUTICS / GREGORY L WEAVER ownership change
4
ATOS Atossa Therapeutics Inc.
19 May 20
ATOSSA THERAPEUTICS / Richard I Steinhart ownership change
4
Chen Shu-Chih
19 May 20
ATOSSA THERAPEUTICS / Shu-Chih Chen ownership change
4
Stephen J Galli
19 May 20
ATOSSA THERAPEUTICS / Stephen J Galli ownership change
8-K
ATOS Atossa Therapeutics Inc.
19 May 20
Submission of Matters to a Vote of Security Holders
10-Q
2020 Q1
ATOS Atossa Therapeutics Inc.
13 May 20
Quarterly report
8-K
ATOS Atossa Therapeutics Inc.
13 May 20
Atossa Therapeutics Announces First Quarter 2020 Financial Results and Provides Company Update on COVID-19 HOPE and Endoxifen Programs
4
ATOS Atossa Therapeutics Inc.
13 Apr 20
ATOSSA THERAPEUTICS / Kyle Guse ownership change